List of therapeutic monoclonal antibodies - Wikipedia This list of over 500 monoclonal antibodies includes approved and investigational drugs as well as drugs that have been withdrawn from market; consequently, the column Use does not necessarily indicate clinical usage See the list of FDA-approved therapeutic monoclonal antibodies in the monoclonal antibody therapy page
Antibody therapeutics approved or in regulatory review in the EU or US Access YAbS, an online database of antibody therapeutics No login is needed to access data on approved antibody therapeutics, or those in regulatory review or in late-stage clinical studies The Antibody Society
What Are the FDA-Approved Monoclonal Antibodies? These lab-made proteins are designed to mimic natural antibodies found in our immune system Natural antibodies fight off infections by identifying and attacking harmful cells Monoclonal antibodies do the same but with a high degree of precision
A Look Back: FDA Approval of Monoclonal Antibodies in 2023 As of December 31, 2023, the Food and Drug Administration (FDA) records that a total of 55 new drugs were approved in 2023 Among them, 28 are small molecule drugs, constituting 51% of the total approved drugs, while 12 are antibody drugs
Table of monoclonal antibodies with a valid marketing authorisation . . . Monoclonal antibodies are usually genetically modified antibodies They are used both in diagnostics and in therapies, and here, in particular in immune suppression and cancer therapy The list of medicines contains the products that have a valid marketing authorization
List of Cleared or Approved Companion Diagnostic Devices For a list of all FDA cleared or approved nucleic acid based tests, see Nucleic Acid Based Tests Please submit any questions to DICE@fda hhs gov Eligible alleles: HLA-A*02:01,
FDA Approved Antibody-Drug Conjugates (ADCs) By 2025 To date, a total of 15 ADCs have been approved by the FDA, including: ado-trastuzumab emtansine (Kadcyla™), brentuximab vedotin (Adcetris™), inotuzumab ozogamicin (Besponsa™), gemtuzumab ozogamicin (Mylotarg™) , Moxetumomab pasudotox (Lumoxiti™, discontinued in the U S market ), polatuzumab vedotin-piiq (Polivy™), Enfortumab vedotin (Padcev™),
FDA Approved Antibodies - Immunology FDA Approved Antibody-based Therapeutics CD Antigens Graduate Programs Search Jobs Literature Searches FDA Approved Antibodies Antibodies in Clinical Trials Online Journals Fellowships Grants Find Antibodies Search Books Find Products Associations Cancer Info Gene Databases Protein Databases KO Transgenic Mice Biotechnology Info Find a Scientist Clinical Trials Search Patents Meeting